Literature DB >> 3002587

Morphologic variations of small cell lung cancer. A histopathologic study of pretreatment and posttreatment specimens in 104 patients.

M Sehested, F R Hirsch, K Osterlind, J E Olsen.   

Abstract

A consecutive series of 104 autopsies on patients treated in protocol for small cell carcinoma of the lung (SCCL) was studied with respect to metastatic pattern at autopsy in relation to pretreatment WHO 1981 classification, and extent and significance of non-SCCL tumor tissue at autopsy. The only significant difference in the metastatic pattern at autopsy between patients with pretreatment oat cell or intermediate subtype was metastases to the brain. Thus, the frequency of brain metastases was 17/35 (49%) in patients with oat cell type compared to 2/18 (11%) in patients with intermediate type (P less than 0.05). At autopsy 13 of 98 patients (13%) had non-SCCL tumor tissue in at least one site. These patients had a significantly shorter survival (P = 0.020) compared to patients with pure SCCL at autopsy. Furthermore, none of these 13 patients had obtained complete remission. Whether these morphologic variations had been present at the pretreatment stage of the disease or were due to the chemotherapeutic treatment could not be solved in the present study. However, the results might indicate that mixed SCCL/non-SCCL histology is a negative prognostic factor in the treatment of SCCL. Prospective studies including more extensive pretreatment tissue sampling seem to be required.

Entities:  

Mesh:

Year:  1986        PMID: 3002587     DOI: 10.1002/1097-0142(19860215)57:4<804::aid-cncr2820570420>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Surgery for combined type small cell lung carcinoma.

Authors:  R Hage; J R Elbers; A Brutel de la Rivière; J M van den Bosch
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

2.  TRP53 Mutants Drive Neuroendocrine Lung Cancer Through Loss-of-Function Mechanisms with Gain-of-Function Effects on Chemotherapy Response.

Authors:  Nagako Akeno; Alisa L Reece; Melissa Callahan; Ashley L Miller; Rebecca G Kim; Diana He; Adam Lane; Jonathan S Moulton; Kathryn A Wikenheiser-Brokamp
Journal:  Mol Cancer Ther       Date:  2017-08-28       Impact factor: 6.261

Review 3.  Small-cell lung cancer.

Authors:  Charles M Rudin; Elisabeth Brambilla; Corinne Faivre-Finn; Julien Sage
Journal:  Nat Rev Dis Primers       Date:  2021-01-14       Impact factor: 52.329

4.  TNM stage, immunohistology, syntactic structure analysis and survival in patients with small cell anaplastic carcinoma of the lung.

Authors:  K Kayser; M Fitzer; H Bülzebruck; K Bosslet; P Drings
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Long-term survival of a patient with stage IV pulmonary large cell carcinoma achieved by combined-modality therapy: report of a case.

Authors:  S Kobayashi; S Okada; T Hasumi; N Sato; S Fujimura
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

6.  Single primary lung cancer consisting of three cancer cell types (small cell carcinoma, adenocarcinoma, and squamous cell carcinoma) in which each had metastasized to different lymph nodes.

Authors:  Hiroo Shikata; Yoshimichi Ueda; Shuji Tsuchishima; Toshimichi Nonaka; Yoh Watanabe; Junichi Matsubara
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-05

7.  Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases.

Authors:  Yue-Ya Li; Chan Zhou; Deng-Xia Yang; Jing Wang; Zhu-Jun Liu; Xin-Yue Wang; Kai Li
Journal:  Cancer Biol Med       Date:  2015-06       Impact factor: 4.248

8.  Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes.

Authors:  Alexander Krohn; Theresa Ahrens; Arzu Yalcin; Till Plönes; Julius Wehrle; Sanaz Taromi; Stefan Wollner; Marie Follo; Thomas Brabletz; Sendurai A Mani; Rainer Claus; Björn Hackanson; Meike Burger
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

9.  Chemo-radioresistance of small cell lung cancer cell lines derived from untreated primary tumors obtained by diagnostic bronchofiberscopy.

Authors:  Y Tanio; M Watanabe; T Inoue; I Kawase; T Shiraska; T Ikeda; H Hara; T Masuno; S Saito; K Kawano
Journal:  Jpn J Cancer Res       Date:  1990-03

10.  [A case report of combined small cell lung cancer with EGFR mutation and treatment experience].

Authors:  Ye Guo; Limei Qu; Mingxin Shao; Xingxing Wang; Hongwei Sun; Kewei Ma
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.